New asthma inhaler faces off against standard treatment in major trial
NCT ID NCT07318350
First seen Jan 08, 2026 · Last updated May 12, 2026 · Updated 23 times
Summary
This study tests a new inhaler medicine (N0783) to see if it works as well as a standard asthma inhaler (Alenia®) for people with moderate asthma. About 174 adults will take one of the two inhalers for 12 weeks. Researchers will measure lung function and symptom control to confirm the new option is not worse than the current treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.